发明名称 Non-invasive refractive treatment using nanoparticles
摘要 Embodiments of this invention generally relate to systems and methods for optical treatment and more particularly to non-invasive refractive treatment method based on sub wavelength particle implantation. In an embodiment, a method for optical treatment identifies an optical aberration of an eye, determines a dopant delivery device configuration in response to the optical aberration of the eye, wherein the determined dopant delivery device is configured to impose a desired correction to the eye to mitigate the identified optical aberration of the eye by applying a doping pattern to the eye so as to locally change a refractive index of the eye.
申请公布号 US9603699(B2) 申请公布日期 2017.03.28
申请号 US201514971861 申请日期 2015.12.16
申请人 AMO Wavefront Sciences, LLC 发明人 Raymond Thomas D.;Copland Richard J.
分类号 A61F9/01;A61F9/007;A61K9/00;A61F2/14;A61K33/24 主分类号 A61F9/01
代理机构 Abbott Medical Optics Inc. 代理人 Abbott Medical Optics Inc.
主权项 1. A method for optical treatment, the method comprising: identifying an optical aberration of an eye, determining a dopant delivery device configuration in response to the optical aberration of the eye to impose a desired correction to change an index of refraction of cornea of the eye to mitigate the identified optical aberration of the eye by delivering a dopant according to a doping pattern to cornea of the eye, wherein the delivered dopant locally changes refractive index values of the cornea without reshaping the cornea, and configuring the dopant delivery device as determined, wherein configuring the dopant delivery device comprises activating the dopant located on first portions of a contact lens by a selective irradiation of the first portions of the dopant delivery device.
地址 Santa Ana CA US